Search company, investor...
Qlucore company logo

Qlucore

qlucore.com

Founded Year

2007

Stage

IPO | IPO

Total Raised

$4.81M

Date of IPO

11/11/2021

Market Cap

0.08B

About Qlucore

Qlucore offers tools to analyze and visualize data. The tools use AI and machine learning. It focuses on pharmaceutical companies and universities. The company was founded in 2007 and is based in Lund, Sweden.

Headquarters Location

Ideon Science Park Scheelevägen 17

Lund, 223 70,

Sweden

+46 46 286 3110

Missing: Qlucore's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Qlucore's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Qlucore

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Qlucore is included in 3 Expert Collections, including Biopharma Tech.

B

Biopharma Tech

5,241 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

O

Omics

1,267 items

Companies involved in the capture, sequencing, and/or analysis of genomic, transcriptomic, proteomic, and/or metabolomic data

D

Digital Health

13,069 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)

Latest Qlucore News

Qlucore participates in major EU project to prevent cardiovascular diseases

Dec 15, 2022

Qlucore participates in major EU project to prevent cardiovascular diseases Qlucore participates in major EU project to prevent cardiovascular diseases – Receives over EUR 436k to contribute to improved cardiovascular health Nasdaq First North-listed Qlucore, a leading software provider of visualization-based software for research-oriented data analysis and precision diagnostics, receives EUR 436k for participation in CARE-IN-HEALTH, a major EU project that will give people tools for improved health. The project will last five years and is the second recent project that the company has received a grant to participate in. Cardiovascular diseases (CVD) are the world's leading cause of death and affect over 49 million people annually. The cost in healthcare and the pressure this puts on providers is high, EUR 90 billion per year for the EU alone, despite progress in the prevention and treatment of CVD. To promote health, this EU project will develop and test tools for both healthcare providers and patients, so-called precision medicine. The solutions are aimed at remedying the chronic inflammation that leads to plaques in the arteries that in turn trigger the formation of blood clots. This is the main cause of heart attack and stroke. ”This project aims to improve the preventive treatment of patients at higher risk of cardiovascular disease by using precision medicine. The goal is to find early strategies to interrupt the inflammatory processes that lead to cardiovascular risk. This can provide significant benefits for society,” says Professor Magnus Bäck, project coordinator for CARE-IN-HEALTH. ”In addition to our ongoing work in cancer diagnostics, this is the second recent project in cardiovascular diseases that we have received funding for and it shows how relevant our solutions are. We will contribute with software and knowledge in machine learning to establish solutions so that a person’s risk of being affected can be reduced” says Carl-Johan Ivarsson, CEO of Qlucore. The project will involve ten participants, the two Swedish participants are from Karolinska Institutet and Qlucore. The project coordinator is Magnus Bäck of INSERM in France. Certified Advisor

Qlucore Frequently Asked Questions (FAQ)

  • When was Qlucore founded?

    Qlucore was founded in 2007.

  • Where is Qlucore's headquarters?

    Qlucore's headquarters is located at Ideon Science Park, Lund.

  • What is Qlucore's latest funding round?

    Qlucore's latest funding round is IPO.

  • How much did Qlucore raise?

    Qlucore raised a total of $4.81M.

  • Who are the investors of Qlucore?

    Investors of Qlucore include Eiffel Investment Group, ALMI and Seventh Framework Programme.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.